Critical Care, Sleep and Pulmonary Medicine

Back to Results

Nicole F Ruopp, MD Accepting New Patients


Training + Education University of Arkansas for Medical Sciences; Duke University/Duke University Medical Center (Internal Medicine Residency), Boston University/Boston Medical Center (Pulmonary and Critical Care Fellowship), Harvard Medical School/Brigham and Women's Hospital (Advanced Fellowship in Pulmonary Hypertension)
Board Certifications Internal Medicine, Pulmonary Medicine
NPI # 1972820918
Gender Female
Accepted Insurances View Accepted Insurances at Tufts MC + Tufts Children's Hospital

Tufts Medical Center
Biewend Building
260 Tremont Street
Boston, MA 02111
Phone #: 617-636-6377
Fax #: 617-636-1649

Ruopp NF, Farber HW. Gaps and controversies of new treatment recommendations in recent pulmonary hypertension guidelines: What we know and what we don’t. Advances in Pulmonary Hypertension 2017;16(1):20-25.
Parikh K, Dahhan T, Nicholl L, Ruopp N, Pomann GM, Fortin T, Tapson V, Rajagopal S. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. Scientific Reports 2019;9:4061.
Ruopp NF, Schoenberg NC, Farber HW. Swan-Ganz and Pericardial Pressure-Guided Pericardiocentesis in Pulmonary Arterial Hypertension-Associated Cardiac Tamponade. Annals of the American Thoracic Society 2019;16(9):1189-1191.
Ruopp NF, Farber HW. The new World Symposium on Pulmonary Hypertension guidelines: Should twenty-one be the new twenty-five? Circulation 2019;140:1134-1136.
Ruopp NF, Maron BA. Pulmonary Hypertension in the modern era: the intersection of genotype and phenotype. Journal of Heart and Lung Transplant 2020 Feb;39(2):113-114. Epub 2019 Nov 9.
Schoenberg NC, Ruopp NF, Farber HW. A 46-Year Old Man on Hemodialysis with Dyspnea and an Abnormal Echocardiogram. Annals of the American Thoracic Society 2019;16:1577-1581.
Ruopp NF, Farber HW. The Elephant Man Meets Pulmonary Hypertension: A Cautionary Tale. American Journal of Respiratory and Critical Care Medicine 2020: 15;202(6):789-791.
Shioleno AM, Ruopp NF. Group 3 Pulmonary Hypertension: A Review of Diagnostics and Clinical Trials. Clinics in Chest Medicine 2021: Mar;42(1):59-70.
Cramer-Bour C, Ruhl AP, Nouraie SM, Emeh RO, Ruopp NF, Thein SL, Weir NA, Klings ES. Long Term Tolerability of Phosphodiesterase-5 Inhibitors in Sickle Cell Disease. Eur J Haematol. 2021 Jul;107(1):54-62. Epub 2021 Apr 15.
Menon AM, Ruopp NF, Parakh A, Cockrill B, Waxman AB. A 65-year-old woman with a repaired atrial septal defect and pulmonary hypertension with worsening dyspnea. Annals of the American Thoracic Society. 2021 Jun;18(6):1052-1058.
Ruopp NF, Waxman AB. (2019). ‘Group 1 Clinical Features and Treatment’ in Peacock A (ed.) The Encyclopedia of Respiratory Medicine, 2nd Edition, in press.